Hepatic CT perfusion CT for the therapeutic response of sorafenib for hepatocellular carcinoma
Not Applicable
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000011522
- Lead Sponsor
- Hiroshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
(a) Patients who have allergy to CT contrast media (b) Patients whose performance status is severe (c) Patients with bronchial asthma (d) Patients with severe renal dysfunction (eGFR lower than 30ml/min/1.73m2) (e) Patients who are pregnant or lactating patients (f) Patients whom doctor in charge has decided to be inappropriate for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine clinical utility of hepatic CT perfusion
- Secondary Outcome Measures
Name Time Method